이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Assertio Holdings 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Brendan O’Grady

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	less than a year
CEO 소유권	n/a
경영진 평균 재임 기간	less than a year
이사회 평균 재임 기간	less than a year

최근 관리 업데이트

Recent updates

Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

May 07

Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Apr 18

Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

Mar 13

We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Apr 26

Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Mar 02

CEO

Brendan O’Grady

less than a year

테뉴어

Mr. Brendan P. O'Grady serves as CEO & Director at Assertio Holdings, Inc. since May 29, 2024. Mr. O’Grady is a senior healthcare executive with more than 30 years of experience accelerating sales growth a...

리더십 팀

이름	위치	테뉴어	보상	소유권
Ajay Patel	Senior VP & CFO	less than a year	US$1.06m	0.16% $ 210.0k
Paul Schwichtenberg	Senior Vice President & Chief Commercial Officer	less than a year	US$1.09m	0.13% $ 170.1k
Brendan O’Grady	CEO & Director	less than a year	데이터 없음	데이터 없음
Bill Iskos	Senior Vice President of Operations	2.9yrs	데이터 없음	데이터 없음
Molly Dir	Senior Vice President of HR & Administration ?	less than a year	데이터 없음	데이터 없음
Sam Schlessinger	Senior VP & General Counsel	3.4yrs	데이터 없음	0.13% $ 166.0k
Howard Franklin	Senior Vice President of Medical	1.3yrs	데이터 없음	데이터 없음

0.7yrs

평균 재임 기간

42yo

평균 연령

경험이 풍부한 관리: ASRT 의 관리팀은 경험 (평균 재직 기간 0.6 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Brendan O’Grady	CEO & Director	less than a year	데이터 없음	데이터 없음
Peter Staple	Independent Chairman	20.7yrs	US$377.45k	0.33% $ 423.9k
William McKee	Independent Director	7.3yrs	US$356.52k	0.013% $ 16.8k
Heather Mason	Independent Director	5.4yrs	US$353.02k	0.22% $ 289.2k
Sigurd Kirk	Independent Director	less than a year	데이터 없음	데이터 없음
Jeffrey Vacirca	Independent Director	less than a year	US$245.84k	0.066% $ 85.2k
Sravan Emany	Independent Director	less than a year	US$223.80k	데이터 없음

1.0yrs

평균 재임 기간

59.5yo

평균 연령

경험이 풍부한 이사회: ASRT 의 이사회는 경험(평균 재직 기간 0.9 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Assertio Holdings 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Assertio Holdings, Inc. Announces the Appointment of Brendan P. O’Grady as CEO

Assertio Holdings, Inc., Annual General Meeting, May 23, 2024

Assertio Holdings, Inc. Announces the Resignation of Daniel A. Peisert as Member of the Board of Directors

Assertio Holdings, Inc. Announces Executive Changes

Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors

Assertio Holdings, Inc. Announces CFO Changes

Recent updates

Assertio Holdings, Inc. Announces the Appointment of Brendan P. O’Grady as CEO

The Buxton Helmsley Group Sends Letter to Assertio Holdings

The Buxton Helmsley Group Sends Letter to Assertio Holdings

Assertio Holdings, Inc. Reiterates Earnings Guidance for the Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Assertio Holdings, Inc. to Report Q1, 2024 Results on May 06, 2024

Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Assertio Holdings, Inc., Annual General Meeting, May 23, 2024

Consensus revenue estimates fall by 27%

Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

Full year 2023 earnings: EPS misses analyst expectations

Assertio Holdings, Inc. Provides Earnings Guidance for the Year 2024

Assertio Holdings, Inc. to Report Q4, 2023 Results on Mar 11, 2024

New major risk - Share price stability

Assertio Holdings, Inc. Announces the Resignation of Daniel A. Peisert as Member of the Board of Directors

Bragar Eagel & Squire, P.C. Announces Class Action Lawsuit Against Assertio Holdings, Inc

Assertio Holdings, Inc. Announces Executive Changes

Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors

New minor risk - Market cap size

Assertio Holdings, Inc. Announces CFO Changes

New minor risk - Profitability

Consensus EPS estimates fall by 18%

Assertio Holdings, Inc. to Report Q3, 2023 Results on Nov 08, 2023

President recently sold US$479k worth of stock

President notifies of intention to sell stock

New major risk - Shareholder dilution

Independent Director notifies of intention to sell stock

New minor risk - Share price stability

Assertio Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $25 million.

Consensus revenue estimates increase by 13%, EPS downgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Assertio Holdings, Inc. Withdraws Earnings Guidance for the Year 2023

Assertio Holdings, Inc. (NasdaqCM : ASRT) completed the acquisition of Spectrum Pharmaceuticals, Inc. (NasdaqGS : SPPI).

Assertio Holdings, Inc. Appoints Jeffrey Vacirca to Its Board of Directors

Assertio Holdings, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Independent Director recently sold US$652k worth of stock

President exercised options and sold US$2.9m worth of stock

Consensus EPS estimates fall by 30%, revenue upgraded

Assertio Holdings, Inc. Raises Earnings Guidance for the Full Year of 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Director notifies of intention to sell stock

Investor sentiment deteriorates as stock falls 17%

We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Now 21% undervalued

Price target increased by 9.6% to US$7.88

Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Investor sentiment improves as stock rises 18%

Consensus EPS estimates increase by 164%

President exercised options and sold US$257k worth of stock

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 11%

Investor sentiment deteriorated over the past week

Insufficient new directors

Assertio Holdings, Inc. Revises Net Product Sales Guidance for the Year 2022

Assertio Holdings, Inc. Revises Earnings Guidance for the Full Year 2022

Assertio Holdings, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Assertio Holdings Looks Good To Rebound After Recent Price Plunge

Assertio Holdings: Substantial Upside

Assertio Holdings, Inc. Raises Earnings Guidance for the Year 2022

Assertio Therapeutics Q2 2022 Earnings Preview

Assertio Holdings, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Assertio Holdings: Management Still Swimming Against The Tide

Assertio's Phenomenal Turnaround

Assertio Holdings, Inc. Re-Affirms Sales Guidance for the Full Year of 2022

Levi & Korsinsky, LLP Announces Propose Settlement Against Assertio Therapeutics, Inc. Securities Litigation

Assertio Holdings, Inc. to Report Q1, 2022 Results on May 09, 2022

Assertio Holdings: Recent Breakout To Lead To Sustained Gains